Report: Pipeline of Alzheimer ’ s drugs ‘ due for big victories ’ in next 5 years

There are twenty-seven Alzheimer’s drugs in late-stage clinical trials and eight candidates in Phase II programs that could launch in the next 5 years, according to an analysis presented this week at the Alzheimer’s Association International Conference. “The Alzheimer’s disease pipeline, marred by decades of failures and underinvestment, is due for big victories,” UsAgainstAlzheimer’s co-founder & chairman George Vradenburg said in prepared remarks. “Thanks to growing investment from industry leaders, we remain cautiously optimistic that the current crop of late-stage Alzheimer’s innovations will bring much-needed solutions to families in the near future.” Get the full story at our sister site, Drug Delivery Business News. The post Report: Pipeline of Alzheimer’s drugs ‘due for big victories’ in next 5 years appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Tags: Neurological Pharmaceuticals Research & Development Source Type: news